Katy Hwang

Katy Hwang assists the Biotechnology Group in patent prosecution.

Recent Posts

In Prior Art, Don’t Overlook What’s Inherently There

Posted by Katy Hwang on Mar 20, 2017

Katy Hwang

You can’t prepare for something that you can’t see. Newly recognized properties of previous discoveries or other inherent features not appreciated at the time of filing can sneak up on you after patent prosecution has ended, as was the case in the recent decision in Pharmacosmos A/S, v. Luitpold Pharmaceuticals, Inc. (IPR2015-01490).

Read More

Topics: BioPharma

Wolf Greenfield's Post-Grant Blog

Here, the Post-Grant Proceedings Group
at Wolf Greenfield keeps you up to date
on the latest decisions and best practices, and what they mean for you. Learn more about the group and its members.

New Call-to-action
New Call-to-action
New Call-to-action

Subscribe to Email Updates

Recent Posts

Follow Us

This blog is intended to promote thought and debate on developing areas of the law. The opinions, commentary and characterizations of cases provided on this blog are not legal advice and do not represent the opinions of Wolf Greenfield or its clients.